CoChat

Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo‐Controlled Trial

Open access
de Bejczy, Andrea, Löf, Elin, Walther, Lisa, Guterstam, Joar, Hammarberg, Anders, Asanovska, Gulber, Franck, Johan, Isaksson, Anders, Söderpalm, Bo · 2015 · Alcoholism: Clinical and Experimental Research
Cited by 105

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background: Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α 4 β 2 nicotinic acetylcholine receptors. Methods: A total of 160 subjects, 30 to 70 years of age, fulfilling DSM‐IV criteria for alcohol dependence without any serious physical or mental disorders, were recruited through advertisement at 3 university clinics in Sweden during March 2009 to January 2011. After a 2‐week placebo run‐in period, subjects received 2 mg varenicline daily (titrated from 0.5 mg during first week) or placebo for 12 weeks in a double‐blind manner. Results: The primary outcome was the proportion of heavy drinking days, measured by self‐reported alcohol consumption. Primary and secondary outcomes were calculated as a mean over the 10‐week steady‐state active treatment period. In the primary outcome analysis, no effect of varenicline over placebo was found (p = 0.73 for the intention to treat [ITT] and 0.92 for per protocol [PP]). Secondary outcome analysis found a significant reduction of specific alcohol marker phosphatidylethanol (PE th) in the blood in the varenicline group compared to placebo (p = 0.02 ITT). Craving (p = 0.048 PP) and Alcohol Use Disorders Identification Test (AUDIT) scores (p = 0.015 ITT) were also reduced in the active treatment group. PE th more strongly correlated with self‐reported alcohol consumption than carbohydrate‐deficient ttransferrin and γ‐glutamyl transferase, and correlation coefficients were higher in the varenicline group than in the placebo group for all markers. Conclusions: Although the results of the main outcome of this study did not support an effect of varenicline in alcohol‐dependent individuals, the secondary analyses of PE th, craving and AUDIT score support an effect of varenicline on alcohol consumption. The disclosure of a treatment effect and the lack of a clear placebo effect when using PE th as outcome variable, together with a nonsymmetric bias associated with self‐reported data, strongly argue for using the specific biomarker PE th in studies of treatments of alcohol dependence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acer.12854

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 105

Metadata

Authors
de Bejczy, A., Löf, E., Walther, L., Guterstam, J., Hammarberg, A., Asanovska, G., Franck, J., Isaksson, A., & Söderpalm, B.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
2015-09-28
Volume
39
Issue
11
Pages
2189-2199
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W1936223934
Cited by
105
References
10
FWCI
6.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.